Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease: A Randomized Placebo-Controlled Clinical Trial.

John P Hanrahan Ian H de BoerGeorge L BakrisPhebe J WilsonJames D WakefieldJelena P SeferovicJennifer G ChickeringYueh-Tyng ChienKenneth CarlsonMichael D CressmanMark G CurrieG Todd MilneAlbert T Profy

Published in: Clinical journal of the American Society of Nephrology : CJASN (2020)

A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy/Diabetic Kidney Disease as Measured by Albuminuria, NCT03217591.

Keyphrases

diabetic nephropathy
clinical trial
double blind
placebo controlled
type diabetes
wound healing
phase ii
study protocol
phase iii
open label
randomized controlled trial
radiation therapy
phase ii study
locally advanced
rectal cancer